08045804946
medisus.pharma007@gmail.com
Change Language
MABALL 500MG INJ

MABALL 500MG INJ

6000.0 INR/Number

Product Details:

  • Life Span Check manufacture and expiry date on pack; usually 24 months shelf life
  • Dosage Form Parenteral (Injection)
  • Packaging Type Glass vial
  • Salt Composition Rituximab
  • Brand Name MABALL 500MG INJ
  • Origin of Medicine India
  • Pacakaging (Quantity Per Box) Single vial packaging
  • Click to View more
X

MABALL 500MG INJ Price And Quantity

  • 6000.0 INR/Number
  • 1 Number
  • Intravenous Infusion
  • 10 mg/ml
  • Antineoplastic, Immunosuppressant
  • Hypersensitivity to Rituximab or murine proteins, active severe infections
  • Clear to opalescent, colorless to pale yellow solution
  • Monitor for infusion-related reactions and infections during therapy
  • Required before administration; see leaflet for instructions
  • Prescription only (Rx)
  • Sterile, non-pyrogenic saline solution
  • 24 months from date of manufacture
  • Infusion reactions, fever, chills, infections, rash, low blood cell counts

MABALL 500MG INJ Product Specifications

  • India
  • As prescribed by physician; typically diluted in saline and administered intravenously
  • Adults
  • Rituximab
  • MABALL 500MG INJ
  • Store at 2C - 8C. Do not freeze. Protect from light.
  • Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis
  • Liquid Injection
  • Monoclonal Antibody
  • Single vial packaging
  • Cancer (Lymphoma, Leukemia), Autoimmune diseases
  • To be administered by healthcare professionals only. Dosage and frequency depend on indication and patient response.
  • 1 vial of 50 ml
  • Check manufacture and expiry date on pack; usually 24 months shelf life
  • Rituximab 500mg
  • Monoclonal antibody therapy for cancer and autoimmune disorders
  • Glass vial
  • Parenteral (Injection)
  • Intravenous Infusion
  • 10 mg/ml
  • Antineoplastic, Immunosuppressant
  • Hypersensitivity to Rituximab or murine proteins, active severe infections
  • Clear to opalescent, colorless to pale yellow solution
  • Monitor for infusion-related reactions and infections during therapy
  • Required before administration; see leaflet for instructions
  • Prescription only (Rx)
  • Sterile, non-pyrogenic saline solution
  • 24 months from date of manufacture
  • Infusion reactions, fever, chills, infections, rash, low blood cell counts

MABALL 500MG INJ Trade Information

  • Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)
  • 1000 Number Per Week
  • 2 Days
  • No
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

  • Active Ingredient: Rituximab (500mg).
  • Drug Class: Anti-CD20 monoclonal antibody.
  • Administration: Intravenous (IV) infusion, given by a healthcare professional.
Uses:
  • Cancers: Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL).
  • Autoimmune Diseases: Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), Pemphigus Vulgaris (PV).
How it Works:
  • Targets and binds to the CD20 protein on B-lymphocytes (a type of white blood cell).
  • Flags these cells for destruction by the immune system or inhibits cell growth, reducing cancer or inflammation.


Precision Treatment for Cancer and Autoimmune Conditions

MABALL 500MG INJ delivers targeted monoclonal antibody therapy, effectively managing Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and specific autoimmune diseases. Its action is precise, helping to minimize damage to healthy tissues while providing potent anti-cancer and immunosuppressive effects. This treatment option represents an advanced approach in modern medicine for eligible adults.


Professional Preparation and Administration

Before administration, MABALL 500MG INJ must be carefully reconstituted and diluted using sterile, non-pyrogenic saline. Only trained healthcare professionals should handle this process and perform the intravenous infusion, ensuring optimal efficacy and safety. Detailed instructions for preparation can be found in the manufacturer's leaflet.


Storage and Handling Guidance

To maintain stability and potency, MABALL 500MG INJ should be stored between 2C and 8C, away from light and never frozen. Ensure to check both the manufacture and expiry date on the pack before use. These measures are critical for preserving the medication's effectiveness throughout its 24-month shelf life.

FAQ's of MABALL 500MG INJ:


Q: How should MABALL 500MG INJ be administered?

A: MABALL 500MG INJ is administered by intravenous infusion only. It must be prepared and given by a healthcare professional after proper reconstitution and dilution in a sterile, non-pyrogenic saline solution.

Q: What medical conditions does MABALL 500MG INJ treat?

A: MABALL 500MG INJ is prescribed for Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis in adults.

Q: When should MABALL 500MG INJ not be used?

A: MABALL 500MG INJ should not be used by individuals with known hypersensitivity to Rituximab or murine proteins, or in cases of active severe infections. Always inform your doctor of your medical history before starting therapy.

Q: Where should MABALL 500MG INJ be stored before use?

A: Store the vial in a refrigerator at 2C to 8C, protect it from light, and do not freeze. These conditions help maintain the medication's stability and effectiveness.

Q: What is the process for preparing MABALL 500MG INJ for use?

A: The injection requires reconstitution and dilution before administration. A healthcare professional will follow detailed preparation instructions provided in the patient leaflet to ensure safe and effective use.

Q: What are the potential side effects associated with MABALL 500MG INJ?

A: Possible side effects include infusion reactions, fever, chills, infections, rashes, and low blood cell counts. Patients are monitored closely during therapy to manage any adverse effects promptly.

Q: What are the main benefits of using MABALL 500MG INJ for treatment?

A: MABALL 500MG INJ offers targeted monoclonal antibody therapy, which can significantly improve outcomes in cancer and autoimmune disorders by specifically targeting disease-causing cells while minimizing damage to healthy tissues.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicines' category



Back to top